The Princess Margaret Elders

Dr. David Warr

Chair, Elders Council

Dr. Warr was an Associate Professor in the Department of Medicine at the University of Toronto, and past Head of Breast Cancer Medical Oncology and Solid Tumour Ward Chief at Princess Margaret Cancer Centre in Toronto, Canada where he worked from 1984 to 2020. He is Past President of the Multinational Association of Supportive Care in Cancer (MASCC) and received their Distinguished Service Award in 2017. A clinician-teacher with research interests in supportive care and antiemetics, Dr. Warr has lectured on supportive care in over 40 countries; published peer-reviewed articles on antiemetics, bisphosphonates, group support, anticoagulation, hot flashes and pain control; and has contributed to evidence-based guidelines for MASCC-ESMO and Cancer Care Ontario.

Mr. Stephen Bear

Mr. Bear served as a board member of the Princess Margaret Cancer Foundation for nine years including as Chair of the Board for two years. During his 26 years at McKinsey & Company, Mr. Bear led the Firm’s practices in Korea and Canada and focused primarily on serving clients in the financial services and energy sectors. Since his retirement from McKinsey as a Senior Partner in 2013, he has served as a senior advisor on key topics and as a faculty member for various partner training programs. He also serves on the Dean’s Advisory Board for the Rotman School of Business at the University of Toronto.

Dr. Robert Bell

Dr. Bell served as Deputy Minister of Health and Long-Term Care from 2014 to 2018. Prior to this role, he served as President and Chief Executive Officer of University Health Network for nine years. He was previously Chief Operating Officer at Princess Margaret Cancer Centre and Chair of both Cancer Care Ontario's Clinical Council and the Cancer Quality Council of Ontario. As an internationally recognized orthopedic surgeon, health system executive, clinician-scientist, and educator, Dr. Bell has more than 40 years of health care experience.

Mr. Sean Boyd

Mr. Boyd serves as the Executive Chair of the Board of Agnico Eagle Mines Limited. Prior to this role, he was Vice Chairman and the Company’s Chief Executive Officer (CEO) from 1998 to 2022. Before his appointment as CEO, Mr. Boyd served as the Chief Financial Officer from 1990 to 1998 and Comptroller from 1985 to 1990. In December 2020, the Globe and Mail ROB Magazine recognized him as its Global Visionary of the Year CEO. He was recognized as The Northern Miner’s Mining Person of the Year in 2007 and 2017 and appeared on the list of The Best-Performing CEOs in the World in the Harvard Business Review in 2010, 2016 and 2017. In 2019, Mr. Boyd was recognized by the Chartered Professional Accountants of Ontario (CPA Ontario) as a Fellow, the highest honour bestowed upon a CPA within the accounting profession. Mr. Boyd also serves on the Board of Directors of The Princess Margaret Cancer Foundation. He has served on the Boards of the World Gold Council and the St. Francis Xavier University Board of Governors.

Mr. Tom Ehrlich

Mr. Ehrlich is the President of TRAM Developments Inc. as well as Tanurb Developments Inc., two real estate development and management companies based in Toronto. Mr. Ehrlich has been involved with the Princess Margaret Cancer Foundation for over 20 years including serving as a board member for nine years and as Chair of the Board for two years. During his 20 years of involvement with the Foundation, Mr. Ehrlich has been involved in the development and implementation of many important programs including Invest in Research, The Incubator Accelerator Fund and most recently the Space Transformation Campaign. Tom is a strong advocate for both Clinical and Basic Research as well as continually improving patient care and the patient experience. Currently Tom is a member of the UHN Research Committee, Co-Chair of the Princess Margaret Space Transformation Capital Campaign and a member of the Space Transformation Steering Committee.

Ms. Jane Finlayson

Liaison with Young Leaders in Cancer Program

Ms. Finlayson was Senior Public Affairs Advisor and member of the senior management team for Princess Margaret Cancer Centre for 13 years. In that role, she provided strategic project management and communications advice and counsel to executive leadership, while managing a robust media relations program, leading science communications workshops and mentoring staff. Previously, she was Director, Strategic Initiatives and Communications at the Princess Margaret Cancer Centre Foundation, managing media relations, corporate publications, and marketing communications.

Ms. Barbara Fitzgerald

Ms. Fitzgerald has worked in health care, specializing in oncology nursing for over 34 years in both academic and community-based hospital environments. Barb held executive leadership positions in nursing and interprofessional practice at Princess Margaret Cancer Centre, Hamilton Health Sciences Centre, BC Children's and Women's Hospital and the Hospice Centre of Excellence in Vaughan. Her experience also includes working in two global health institutes, a tenure as president of the Canadian Association of Nurses in Oncology and a board member.

Ms. Janice Fukakusa

Ms. Fukakusa is the Chancellor of Toronto Metropolitan University. She serves as a corporate director with extensive banking and financial services experience. She previously served as RBC’s Chief Administrative Officer, Chief Financial Officer, and as a member of RBC’s Group Executive, from which she retired in January 2017 following a distinguished 31-year career. She currently serves on the boards of corporate and not-for-profit organizations. She is a director on the Boards of Brookfield Asset Management, Cineplex, Loblaw, and Riocan, and works with various not-for-profit and charitable organizations including Chairing the Boards of the Japanese Canadian Cultural Centre Foundation, SHEEO, Past Chair, The Princess Margaret Cancer Foundation, and Chancellor of the Canadian Business Hall of Fame. In 2021, Janice Fukakusa was appointed as a member of the Order of Canada for her leadership and mentorship in banking, and for her boundless community engagement, notably in education and health care.

Dr. Mary Gospodarowicz

Dr. Gospodarowicz is a Professor at the University of Toronto, Past Chair of Radiation Oncology and Past Medical Director of Princess Margaret Cancer Centre. Her current interests include staging and prognosis in cancer, global cancer control, quality cancer care, and mentorship. She is a Past President of the Union for International Cancer Control (UICC) and a member of the Board of Directors of the City Cancer Challenge Foundation. Under the auspices of UICC and Lancet Oncology, she led the Global Task Force on Radiotherapy that produced a seminal report on "Expanding global access to radiotherapy". She established the PM Elders in 2017. She is actively engaged in the Princess Margaret Global Cancer Program and the Young Leaders Program, among other initiatives.

Ms. Marianne Harris

Ms. Harris is a Corporate Director, sitting on private, public and non-profit sector boards. She is a member of the Board of Directors of Sun Life Financial Inc. and Sun Life Assurance Company of Canada, Loblaw Companies Limited and President’s Choice Bank. In the non-profit sector, Ms. Harris is Chair of the Toronto Club, a member of the Investment Committee for the Princess Margaret Cancer Foundation, a Director of the Dean's Advisory Council for the Schulich School of Business and a Director of the Advisory Council for The Hennick Centre for Business and Law. Ms. Harris has over three decades of investment banking, leadership and management experience in Canada and the United States. She has a Masters of Business Administration from Schulich School of Business, a Juris Doctor from Osgoode Hall and a Bachelor of Science (Honours) from Queen’s University.

Dr. David Hedley

Dr. Hedley completed his higher specialist training in medical oncology, combined with a graduate program in tumour immunology, at the Royal Marsden Hospital, University of London. Since 1990 he has been a Senior Scientist/Senior Staff Physician at the Princess Margaret Cancer Centre, and Professor of Medicine at the University of Toronto, Canada, with a major clinical and research focus on pancreatic cancer. His laboratory develops flow cytometry techniques to study complex biological processes linked to experimental treatment development and early-phase clinical trials. Dr. Hedley directs the Imaging Mass Cytometry (IMC) Core Facility at Princess Margaret. He plays a major role in international flow cytometry education, having taught numerous courses over more than 20 years. In 2015, Dr. Hedley received the International Society for the Advancement of Cytometry’s Fulwyler Award for innovative excellence in flow cytometry.

Mr. Glenn Ives

Mr. Ives is a Corporate Director. He is a member of the Kinross Gold Corporation, Wheaton Precious Metal Corp. and Nervgen Pharmaceuticals Corp. boards of directors. Mr. Ives served as a board member of the Princess Margaret Cancer Foundation for nine years including as Chair of the Board for two years. During his 20 years as a partner at Deloitte Canada, Mr. Ives served as Chairman for eight years. He also serves as Chairman of the St. Paul’s Foundation (Vancouver), Chair of the University of Waterloo School of Accounting and Finance Advisory Board and on the Boards of Bard on the Beach Shakespeare Festival and West Vancouver United Church. Mr. Ives holds a Bachelor of Mathematics (Hons.) from the University of Waterloo and is a Fellow Chartered Professional Accountant (FCPA, FCA).

Dr. Michael Jewett

Dr. Jewett is a Professor of Surgery (Urology) at Princess Margaret Cancer Centre and the University of Toronto. He served as Chairman and Program Director of the Division of Urology at the University of Toronto and Head of Urology at the University Health Network. He is the founding and immediate past Chair of the Kidney Cancer Research Network of Canada and is Past President of the Canadian Urology Association. He has received multiple awards including the Canadian Urological Association Award, the American Urological Association Distinguished Service Award, the Society of Urologic Oncology Medal and the Société Internationale d'Urologie Distinguished Career Award.

Ms. Karen Maidment

Ms. Maidment is a Corporate Director. She is a member of the Board of Directors of TD Bank, where she chairs the Human Resource and Compensation committee and is a member of the Risk Committee and Corporate Governance committees. Karen is also a member of the TD Ameritrade Board of Directors, where she chairs the Audit Committee. She previously served on the Princess Margaret Foundation Board, the University of Waterloo Board of Governors and TransAlta. Karen has spent over 30 years in financial services and is the former Chief Financial and Administrative Officer of BMO Financial Group. Prior to that, Karen held several executive positions with Mutual Life Insurance company, including CFO. She holds a Bachelor of Commerce from McMaster University and is a Fellow Chartered Professional Accountant (FCPA, FCA).

Ms. Pamela Savage

Chair, Membership Committee

Ms. Savage is the former Director of Professional Practice at Princess Margaret Cancer Centre (2014-2019). She held the role of Nursing Lead for Toronto Central South at Cancer Care Ontario, was an Assistant Clinical Professor in the School of Nursing, Faculty of Health Sciences at McMaster University, and was previously Co-Chair of the Canadian Nurses Association Examination Committee. Ms. Savage's international experience has included oversight for Nursing and Health Professions with the University Health Network's international oncology partners in Qatar and Kuwait and leading the Nursing Philanthropic work to build capacity in Kenya.

Dr. Ian Tannock

Dr. Tannock is Emeritus Professor of Medicine and Medical Biophysics at Princess Margaret Cancer Centre and the University of Toronto. Dr. Tannock was a member of the Board of Directors of the American Society of Clinical Oncology (ASCO) from 2001-2004. He is the recipient of the Warwick Prize from the National Cancer Institute of Canada (2003), and the European Society of Medical Oncology (ESMO) award (2012), and was appointed a Member of the Order of Canada in 2013.

Dr. Padraig Warde

Dr. Warde is a Professor in the Department of Radiation Oncology at the University of Toronto who practiced at the Princess Margaret for over 30 years. He has led the Princess Margaret GU Group for many years leading numerous practice changing clinical trials and was the Deputy Head of the Radiation Medicine Program at PMH between 1999-2012. For the last 15 years, he led the Radiation Treatment Program in Ontario and implemented a comprehensive quality program and a long term strategy for radiotherapy in Cancer Care Ontario/Ontario Health. He has received multiple awards including the Canadian Association of Radiation Oncology Gold Medal and Gordon Richards Lectureship. His current interests include prostate and testicular cancer and mentorship.

Dr. Richard (Dick) Hill

(December 27, 1942 - October 31, 2021)

On October 31, 2021, Dr. Richard (Dick) Hill died peacefully after a long battle with multiple myeloma. Dr. Hill started at Princess Margaret in the late 1960s and went on to have an extraordinary career in oncology research that spanned nearly 50 years. He will be remembered professionally for his mentorship, scholarship, many achievements, and his outstanding commitment and contribution to the field of radiation oncology. Throughout his career, Dr. Hill left an indelible mark on many students in his lab and impacted his field with his research, innovation, and authorship.

Dr. Meredith Giuliani

Education Program

Ms. Meena Merali

PM Administration

Ms. Mary Hooey

Business Admin Manager​